Advanced age and prognosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Brady L. Stein*, B. Douglas Smith

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1161-1163
Number of pages3
JournalLeukemia Research
Issue number9
StatePublished - Sep 2011


  • Chronic myeloid leukemia
  • Dasatinib
  • Elderly
  • Imatinib

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this